Vimarsana
Biggest News Aggregation in the World

Page 2 - Structural Proteins News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Structural Proteins. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Structural Proteins Today - Breaking & Trending Today

Frontiers | Molecular Docking and Dynamics Studies to Explore Effective Inhibitory Peptides Against the Spike Receptor Binding Domain of SARS-CoV-2 - Vimarsana News

Frontiers | Molecular Docking and Dynamics Studies to Explore Effective Inhibitory Peptides Against the Spike Receptor Binding Domain of SARS-CoV-2

The spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a pandemic due to the high transmission and mortality rate of this virus. The world health and economic sectors have been severely affected by this deadly virus, exacerbated by the lack of sufficient efficient vaccines. The design of effective drug candidates and their rapid development is necessary to combat this virus. In this study, we selected 23 antimicrobial peptides from the literature and predicted their structure using PEP-FOLD 3.5. In addition, we docked them to the SARS-CoV-2 spike protein receptor...

Recombinant Proteins Market worth $1.7 billion by 2026 - Emerging Trends, Innovations, Key Industry Insights and Opportunities - Vimarsana News

Recombinant Proteins Market worth $1.7 billion by 2026 - Emerging Trends, Innovations, Key Industry Insights and Opportunities

Recombinant Proteins Market worth $1.7 billion by 2026 – Emerging Trends, Innovations, Key Industry Insights and Opportunities

Recombinant Proteins Market worth $1.7 billion by 2026 - Emerging Trends, Innovations, Key Industry Insights and Opportunities - Vimarsana News

Recombinant Proteins Market worth $1.7 billion by 2026 - Emerging Trends, Innovations, Key Industry Insights and Opportunities

Recombinant Proteins Market worth $1.7 billion by 2026 – Emerging Trends, Innovations, Key Industry Insights and Opportunities

Biosimilars Market worth $44.7 billion by 2026 - Exclusive Report by MarketsandMarkets™ - Vimarsana News

Biosimilars Market worth $44.7 billion by 2026 - Exclusive Report by MarketsandMarkets™

/PRNewswire/ -- According to the new market research report "Biosimilars Market by Product (Monoclonal antibodies (infliximab, rituximab, trastuzumab),...

Global Recombinant Proteins Market Report 2021-2026 - Growth Factors, Chemokines, Structural Proteins, Membrane Proteins - Vimarsana News

Global Recombinant Proteins Market Report 2021-2026 - Growth Factors, Chemokines, Structural Proteins, Membrane Proteins

Share this article Share this article ResearchAndMarkets.com's offering. The global recombinant proteins market is projected to reach USD 1.7 billion by 2026 from USD 1 billion in 2021, at a CAGR of 9.8% during the forecast period. The market growth is primarily driven by factors such as increasing government investments and R&D expenditure in pharmaceutical & biotechnology companies, growing industry academia collaborations, and the patent expiry of biologic products. Emerging markets in Asian countries and the rising focus on personalized medicine & protein therapeutics are other factors ex...